Interferons in relapsing remitting multiple sclerosis.

Interferons in relapsing remitting multiple sclerosis.

Bibliographic Details
Main Author:	Goodin, D
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

Interferons in relapsing remitting multiple sclerosis: a systematic review.
by: Filippini, G, et al.
Published: (2003)

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.
by: Wylezinska, M, et al.
Published: (2003)

Thalamic neurodegeneration in relapsing: Remitting multiple sclerosis
by: Cifelli, A, et al.
Published: (2003)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
by: Petkau, A, et al.
Published: (2004)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis
by: Petkau, A, et al.
Published: (2004)

Cerebellar information processing in relapsing-remitting multiple sclerosis (RRMS).
by: Lesage, E, et al.
Published: (2010)

Management of relapsing-remitting multiple sclerosis: diagnosis and treatment guidelines
by: Paty, D, et al.
Published: (1999)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
by: Ebers, G, et al.
Published: (1998)

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
by: Reder, A, et al.
Published: (2010)

Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis
by: Ahmad, H, et al.
Published: (2018)

De novo relapsing-remitting multiple sclerosis following autologous stem cell transplantation.
by: Armstrong, R, et al.
Published: (2010)

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
by: Dickens, A, et al.
Published: (2014)

Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis.
by: Giorgio, A, et al.
Published: (2010)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
by: Wakerley, B, et al.
Published: (2011)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis (vol 352, pg 1498, 1998)
by: Ebers, G, et al.
Published: (1999)

Management of relapsing-remitting multiple sclerosis: diagnosis and treatment guidelines (vol 6, pg S1, 1999)
by: Paty, D, et al.
Published: (1999)

Interference Effect of Prior Explicit Information on Motor Sequence Learning in Relapsing-Remitting Multiple Sclerosis Patients
by: Zahiri, N., et al.
Published: (2017)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
by: Ebers, G, et al.
Published: (1997)

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
by: Wingerchuk, D, et al.
Published: (2005)

Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article].
by: IFNB Multiple Sclerosis Study Group
Published: (2001)

Surrogate endpoints for EDSS worsening in multiple sclerosis: a meta-analytic approach: measuring disability in relapsing-remitting MS.
by: Ebers, G, et al.
Published: (2011)

Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol
by: Ontaneda, D, et al.
Published: (2020)

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
by: Paty, D, et al.
Published: (1993)

Design and rationale of the determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis (DELIVER-MS) trial
by: Ontaneda, D, et al.
Published: (2018)

A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis
by: Coe, S, et al.
Published: (2019)

Interferon beta treatment of multiple sclerosis.
by: Markovitz, D
Published: (1994)

A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application
by: Yeo, T, et al.
Published: (2020)

DISABILITY PROGRESSION IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) WHO EXPERIENCE DISEASE ACTIVITY DESPITE PREVIOUS DISEASE MODIFYING THERAPY
by: Hettle, R, et al.
Published: (2011)

Systemic interferon alfa in multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1989)

A case of multiple sclerosis—like relapsing remitting encephalomyelitis following allogeneic hematopoietic stem cell transplantation and a review of the published literature
by: Das, J, et al.
Published: (2020)

Unaltered frequency and functionality of CD56bright and CD56dim natural killer cells in untreated relapsing-remitting multiple sclerosis patients
by: Sisay, S, et al.
Published: (2014)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
by: Sibley, W, et al.
Published: (1994)

The effects of Omega-3, Omega-6 Polyunsaturated Fatty Acids (PUFAs) and Vitamin E on patients with the remitting-relapsing (RR) form of Multiple Sclerosis (MS) in Cyprus
by: Loucaides, George N.
Published: (2016)

Treatment of multiple sclerosis with interferon beta-1 b.
by: Abdul-Ahad, A, et al.
Published: (1997)

Breastfeeding and multiple sclerosis relapses: a meta-analysis.
by: Pakpoor, J, et al.
Published: (2012)

Breastfeeding and multiple sclerosis relapses: a meta-analysis
by: Pakpoor, J, et al.
Published: (2012)

The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
by: Kremenchutzky, M, et al.
Published: (1999)

The natural history of multiple sclerosis: a geographically based study 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation
by: Kremenchutzky, M, et al.
Published: (1999)